Global Genital Warts Market, By Morphology (Cauliflower-Like, Smooth Papular, Keratotic, and Flat Warts), Type (Prevention, Diagnostics, Treatment), Cause (HPV 6, HPV 11, Others), Location (Vulva, Cervix Uteri, Urethra, Anus, Scrotum), Gender (Male and Female), Dosage (Cream, Gel, Ointment, Intramuscularly and Others), End-User (Hospitals, Diagnostic Centers, Surgical Centers, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Pharmacy Stores and Others), By Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey and Rest of Europe, China, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific, Brazil, Argentina and Rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Egypt and Rest of the Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Global Genital Warts Market
The global genital warts market is expected to gain market growth in the forecast period of 2020 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.8% in the forecast period of 2021 to 2028 and is expected to reach USD 10,607.81 million by 2028 from USD 6,447.97 million in 2020.
Genital warts are one of the most recurrent types of sexually transmitted infections. The human papillomavirus is the virus responsible for causing genital warts. People will get infected with at least one type of human papillomavirus (HPV) at some point during their lives. Genital warts affect most of the moist tissues in the genital areas of male and female patients. Although the genital infection is asymptomatic, it's frequently recognized as genital warts due to the onset of symptoms. It is estimated that around 1% of sexually active men and women in the United States have genital warts.
Genital warts are caused due to the human papillomavirus (HPV). There are around 30-40 strains of HPV. However, only a few of the strains cause genital warts. The virus is easily transmittable through skin-to-skin contact. Hence it's considered a sexually transmitted infection (STI). The Center for Disease Control and Prevention (CDC) says that people get genital warts due to the mutant activity of HPV.
The surge in prevalence of sexually transmitted diseases (STDs) and human papillomavirus infections, rise in the male population, rise in government initiatives and awareness programs are expected to drive the genital warts market. Moreover, the increase in clinical trials, rise in healthcare expenditure and strategic initiatives by market players, and huge market potential in developing countries bolsters the genital warts market growth. However, the increased cost of treatment for genital warts, the side effects noticed while undergoing treatment for genital warts, and lack of patient and consumer awareness are the restraints that could hinder the growth of the genital warts market. The rise in product recalls associated with vaccines, and topical administration of genital warts and patient compliance regarding the use of vaccines are the restraints that could hinder the market growth.
However, a lack of skilled and qualified professionals could pose a challenge to the growth of the genital warts market.
The global genital warts market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.
Global Genital Warts Market: Scope and Market Size
The global genital warts market is segmented on the basis of morphology, type, cause, location, gender, dosage, end-user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of morphology, the global genital warts market is segmented into flat warts, smooth papular, cauliflower-like, and keratotic. In 2021, the cauliflower-like segment is expected to dominate the global genital warts market due to the high prevalence of this shape of genital warts.
- On the basis of type, the global genital warts market is segmented into prevention, diagnostics, and treatment. In 2021, the prevention segment is expected to dominate the global genital warts market as prevention is increased due to the availability of preventive vaccines.
- On the basis of cause, the global genital warts market is segmented into HPV 6, HPV 11, and others. In 2021, the HPV 6 segment is expected to dominate the global genital warts market owing to the HPV 6 strain having the highest abundance in the diagnostics and have a higher prevalence rate than HPV 11.
- On the basis of location, the global genital warts market is segmented into cervix uteri, urethra, anus, vulva, and scrotum. In 2021, the vulva segment is expected to dominate the global genital warts market because the prevalence rate in women is higher than the men, and vulva have the softest tissue and secretory glands.
- On the basis of gender, the global genital warts market is segmented into male and female. In 2021, the female segment is expected to dominate the global genital warts market due to the higher prevalence or incidence rate.
- On the basis of dosage, the global genital warts market is segmented into cream, gel, ointment, intramuscularly, and others. In 2021, the cream segment is expected to dominate the global genital warts market because treatment with cream is the easiest way to treat genital warts and can be done by the patient itself in the home.
- On the basis of end-user, the global genital warts market is segmented into hospitals, diagnostic centers, surgical centers, ambulatory surgical centers, and others. In 2021, the hospital's segment is expected to dominate the global genital warts market as hospitals patients have all the facilities, and they can directly contact doctors, who can diagnose the disease and give the treatment accordingly.
- On the basis of distribution channels, the global genital warts market is segmented into direct tender, pharmacy stores, and others. In 2021, the direct tender segment is expected to dominate the global genital warts market as there is no requirement of the prescription of doctors and can be purchased and used.
Global Genital Warts Market Country Level Analysis
The global genital warts market is analyzed, and market size information is provided by morphology, type, cause, location, gender, dosage, end-user, and distribution channel.
The countries covered in the genital warts market report are the U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Poland, Turkey, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Lithuania, rest of Europe in Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, rest of Asia-Pacific (APAC) in Asia-Pacific(APAC) Brazil, Argentina, Peru, rest of South America in South America, South Africa, Saudi Arabia, UAE, Israel, Egypt, Kuwait and rest of the Middle East and Africa in the Middle East and Africa (MEA).
The U.S. is expected to dominate the global genital warts market in the North American region due to an increase in the prevalence of STDs and genital warts cases and the rise in product approval. The morphological segment is dominating the U.S. due to the rise in cases and ensures complete treatment and diagnostics in U.S. patients. At the same time, Germany is expected to dominate the global genital warts in the European region due to the presence of untapped opportunities in Germany for genital warts and the increased prevalence of cases of sexually transmitted diseases in Germany. The morphological segment is expected to dominate the market due to an increased preference for minimally invasive methods. Additionally, Japan is expected to dominate the global genital warts in the Asia Pacific region due to increased awareness regarding the treatment for genital warts and favorable reimbursement scenarios in Japan. The morphological segment is expected to dominate the market due to improvement in healthcare architecture in Japan and collaborations between healthcare organizations and market players for the supply of imiquimod medication.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the significant pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
The Growth Potential For Genital Warts In Emerging Economies And The Strategic Initiatives By Market Players Are Creating New Opportunities In The Global Genital Warts Market
The global genital warts market also provides you with detailed market analysis for every country's growth in a particular industry with wound debridement device sales, the impact of advancement in genital warts, and changes in regulatory scenarios with their support for the genital warts market. The data is available for the historical period 2019 to 2020.
Competitive Landscape and Global Genital Warts Market Share Analysis
Global genital warts market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus related to the genital warts market.
The major companies providing the global genital warts are Bausch Health Companies Inc., CryoSurgery, Inc., Merck Sharpe & Dohme Corp., a subsidiary of Merck & Co., Inc., Taro Pharmaceutical Industries Ltd., Glenmark Pharmaceutical Inc., USA (a subsidiary of Glenmark Pharmaceuticals Ltd.), Edge Pharma, CryoConcepts LP, CryoIQ, GlaxoSmithKline plc, ANI Pharmaceuticals, Inc., Cassiopea, Inc., Verrica Pharmaceuticals, Novan, Inc., BioNTech S.E., Serum Institute of India Pvt. Ltd., Fotona, Orgenesis Inc., Perrigo Company plc among others.
The strategic initiatives by market players along with new technological advancements for vaccine production and imiquimod supply for treatment of genital warts, are bridging the gap for treatment.
For instance,
- In June 2020, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., had declared the U.S. FDA approval for GARDASIL9 (Human Papillomavirus 9-valent Vaccine, Recombinant) for the prevention of HPV-related cervical, vaginal, vulvar, anal, oropharyngeal, and other head and neck cancers. The FDA approval received would result in addressing the unmet clinical needs for the patients, increased distribution of the vaccine in hospitals and cancer research institutes, for the rise in product sales.
Collaboration, joint ventures, and other strategies by the market player are enhancing the company market in the global genital warts market, which also provides the benefit for an organization to improve their offering for Treatment Products.
SKU-